Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Mitotane Treatment for Malignant Leydig Cell Tumor: A Case Report
View through CrossRef
ABSTRACTIntroductionLeydig cell tumors (LCTs), constituting 1%–3% of testicular tumors, are mostly benign, but malignant cases present treatment challenges. We report a malignant LCT case with a notable response to mitotane.Case PresentationA 43‐year‐old male presented with a right testicular induration and was diagnosed with a Leydig cell tumor following orchiectomy. BEP chemotherapy was initiated for the liver metastases, but after four cycles, new lymph node and bone lesions appeared. Mitotane was started, which markedly reduced liver and nodal metastases. However, due to fatigue, anorexia, and nipple discomfort, mitotane was discontinued. The disease progressed, and the patient died 4 years post‐diagnosis and 14 months after starting mitotane.ConclusionMitotane shows promise in treating malignant LCTs, but careful management of adverse effects is necessary.
Title: Mitotane Treatment for Malignant Leydig Cell Tumor: A Case Report
Description:
ABSTRACTIntroductionLeydig cell tumors (LCTs), constituting 1%–3% of testicular tumors, are mostly benign, but malignant cases present treatment challenges.
We report a malignant LCT case with a notable response to mitotane.
Case PresentationA 43‐year‐old male presented with a right testicular induration and was diagnosed with a Leydig cell tumor following orchiectomy.
BEP chemotherapy was initiated for the liver metastases, but after four cycles, new lymph node and bone lesions appeared.
Mitotane was started, which markedly reduced liver and nodal metastases.
However, due to fatigue, anorexia, and nipple discomfort, mitotane was discontinued.
The disease progressed, and the patient died 4 years post‐diagnosis and 14 months after starting mitotane.
ConclusionMitotane shows promise in treating malignant LCTs, but careful management of adverse effects is necessary.
Related Results
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract
Introduction
Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct
Introduction
Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Pharmacokinetic interaction between mitotane and etoposide in adrenal carcinoma: a pilot study
Pharmacokinetic interaction between mitotane and etoposide in adrenal carcinoma: a pilot study
Background
The combination of mitotane and platinum-etoposide chemotherapy is a front-line treatment in metastatic adrenocortical carcinoma (ACC), although this...
Clinicopathological Features of Indeterminate Thyroid Nodules: A Single-center Cross-sectional Study
Clinicopathological Features of Indeterminate Thyroid Nodules: A Single-center Cross-sectional Study
Abstract
Introduction
Due to indeterminate cytology, Bethesda III is the most controversial category within the Bethesda System for Reporting Thyroid Cytopathology. This study exam...
Lhb−/−Lhr−/− Double Mutant Mice Phenocopy Lhb−/− or Lhr−/− Single Mutants and Display Defects in Leydig Cells and Steroidogenesis
Lhb−/−Lhr−/− Double Mutant Mice Phenocopy Lhb−/− or Lhr−/− Single Mutants and Display Defects in Leydig Cells and Steroidogenesis
In the mouse, two distinct populations of Leydig cells arise during testis development. Fetal Leydig cells arise from a stem cell population and produce T required for masculinizat...
Data from Imatinib Mesylate Inhibits Leydig Cell Tumor Growth: Evidence for <i>In vitro</i> and <i>In vivo</i> Activity
Data from Imatinib Mesylate Inhibits Leydig Cell Tumor Growth: Evidence for <i>In vitro</i> and <i>In vivo</i> Activity
<div>Abstract<p>Leydig cell tumors are usually benign tumors of the male gonad. However, if the tumor is malignant, no effective treatments are currently available. Ley...
Giant Sacrococcygeal Teratoma in Infant: Systematic Review
Giant Sacrococcygeal Teratoma in Infant: Systematic Review
Abstract
Introduction
Sacrococcygeal teratoma (SCT) is a rare embryonal tumor that occurs in the sacrococcygeal region, with an incidence of about 1 in 35,000 to 40,000 live births...